预热
候选资格
淋巴水肿
医学
梅德林
物理疗法
重症监护医学
内科学
外科
癌症
政治
乳腺癌
政治学
法学
作者
Justin M. Sacks,Brad Riley,David Doubblestein,John P. Kirby,Anna Towers,Kathie S. Weatherly
标识
DOI:10.1007/s12032-024-02449-8
摘要
For over 2 decades, the mainstay of lymphedema treatment has been complete decongestive therapy, however, surgical options are available when conservative treatment is not successful in reducing lymphedema. Standardized pre-surgical and post-surgical guidelines for candidates are not readily available. As part of the 2023 Lymphedema Summit that was sponsored by the American Cancer Society, and the Lymphology Association of North America, an expert consensus workgroup was formed and developed an expert consensus which affirms the importance of pre-surgical guidelines for candidates with lymphedema. The workgroup recommended that guidelines should be tailored to four major end-user groups: (1) patients, (2) referring physicians, (3) allied health professionals, and (4) surgeons.
科研通智能强力驱动
Strongly Powered by AbleSci AI